Rates of Hospitalization and Infection-Related Hospitalization Among HIV-Exposed Uninfected Children Compared to HIV-Unexposed Uninfected Children in the United States, 2007-2016.
Studies from multiple countries have suggested impaired immunity in perinatally HIV-exposed uninfected children (HEU), with elevated rates of all-cause hospitalization and infections. We estimated and compared the incidence of all-cause hospitalization and infection-related hospitalization in the first 2 years of life among HEU and HIV-unexposed uninfected children (HUU) in the U.S. Among HEUs, we evaluated associations of maternal HIV disease-related factors during pregnancy with risk of child hospitalization. HEU data from subjects enrolled in the Surveillance Monitoring for ART Toxicities Study (SMARTT) cohort who were born 2006-2017 were analyzed. HUU comparison data were obtained from the Medicaid Analytic Extract database, restricted to states participating in SMARTT. We compared rates of first hospitalization, total hospitalizations, first infection-related hospitalization, total infection-related hospitalizations, and mortality between HEU and HUU using Poisson regression. Among HEU, multivariable Poisson regression models were fit to evaluate associations of maternal HIV factors with risk of hospitalization. A total of 2,404 HEU and 3,605,864 HUU were included in the analysis. HEU children had ~2 times greater rates of first hospitalization, total hospitalizations, first infection-related hospitalization, and total infection-related hospitalizations compared to HUUs. There was no significant difference in mortality. Maternal HIV disease factors were not associated with the risk of child infection or hospitalization. Compared to HUU, HEU children in the US have higher rates of hospitalization and infection-related hospitalization in the first 2 years of life, consistent with studies in other countries. Closer monitoring of HEU infants for infection and further elucidation of immune mechanisms is needed.